Please login to the form below

Not currently logged in
Email:
Password:

Meda

This page shows the latest Meda news and features for those working in and with pharma, biotech and healthcare.

Mylan agrees to buy Sweden's Meda for $7.2bn

Mylan agrees to buy Sweden's Meda for $7.2bn

After the deal goes through, the Mylan/Meda OTC business will have sales of around $1bn per year, a sizeable tally in a market that despite consolidation remains highly fragmented. ... Adding Meda enhances Mylan's presence in attractive markets such as

Latest news

  • Meda collaborates on asthma comic book Meda collaborates on asthma comic book

    Launches new Explain Asthma volume at ACAAI annual meeting. Meda and Medikiz have launched a new volume in a series of educational healthcare comic books for children. ... Asked why Meda chose to become involved in this project, Loesch said: “ Asthma

  • Cancer drugs lead SMC recommendations Cancer drugs lead SMC recommendations

    People with acne also have access to another treatment after the positive recommendation for Meda Pharmaceuticals' Treclin (clindamycin / tretinoin), while the SMC also gave the green light to the orphan drug

  • Meda agrees $3.1bn takeover of Italy's Rottapharm Meda agrees $3.1bn takeover of Italy's Rottapharm

    Meda said this morning the deal would expand its portfolio of specialty prescription drugs and consumer healthcare products, while also helping it to expand in emerging markets. ... which complement Meda's own operations in countries such as China and

  • Sanofi won't take part in mega-deal trend Sanofi won't take part in mega-deal trend

    Meanwhile, rising Canadian company Valeant is also said to be interested in a $45bn merger with Allergan and generics firm Mylan is attempting to buy Swedish company Meda for $9bn.

  • Mylan raises offer for Meda to $9bn Mylan raises offer for Meda to $9bn

    The board's decision is based on a strong belief in the continued potential of Meda as a stand-alone company," said Meda in a statement issued this morning. ... Mylan's offer could be undermined by the reticence of one of its own shareholders, however,

More from news
Approximately 5 fully matching, plus 20 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    The deal value is approximately $9.9bn when including Meda's net debt, which represents a multiple of around 12.9 x 2015 adjusted EBITDA. ... Licensor Acquired/Licensee Acquirer. Product/Technology. Deal Type. Headline ($m). Meda/Mylan. portfolio of

  • Deal Watch table for July 2014 Deal Watch table for July 2014

    5, 300. Rottapharm/ Meda. Company acquisition . Portfolio of Rx and consumer products.

  • Pharma deals during May 2014 Pharma deals during May 2014

    in Europe, Meda (rejected bid from Mylan), AMco and previously Nycomed (now owned by Takeda).

  • Deal Watch table for August 2013 Deal Watch table for August 2013

    180. GardenHills /. Veropharm. Acquisition. Generic drug manufacture. 151. Acton Pharmaceuticals / Meda.

  • Pharma deals during May 2013 Pharma deals during May 2013

    And, on top of that, at the end of the month there were rumours circulating that the Indian generic company Sun Pharma is seeking to buy Meda for around $5bn. ... Meda's expansion has also been driven by product acquisitions and in the process incurred $2

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Henrik Stenqvist joins Recipharm Henrik Stenqvist joins Recipharm

    Was previously CFO for Meda Group. Recipharm appoints Henrik Stenqvist as its new executive VP and chief financial officer, bringing 24 years of finance and management experience. ... Prior to joining Recipharm, Stenqvist served as CFO for Meda Group and

  • Virgo makes consumer health changes Virgo makes consumer health changes

    include Durex, Nurofen and Meda Pharma.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...

Latest intelligence

The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
Report: Omnichannel advice for the life science industry
In the latest issue of Delta magazine, Fishawack Health's Medical, Marketing, and Consulting experts share their practical advice for creating meaningful omnichannel stakeholder experiences and reveal our proprietary tool for...